Bulgaria · Delayed Price · Currency is BGN · Price in EUR Sopharma AD Company Description
Sopharma AD produces, distributes, and exports pharmaceutical products in Europe, Bulgaria, and internationally.
It offers Carsil to treat liver disease; Tempalgin, a painkiller; Analgin, a pain reliever; Tabex, a drug used for smoking secession; Tribestan, a drug used for stimulation of the male reproductive system; Broncholytin, which is used to suppress cough; Nivalin for use in the peripheral nervous system; Methylprednisolon for severe allergies and life-threatening conditions; Vitamin C; Valeriana, a herbal medicine to reduce the stress; veterinary vaccines; and medical devices, such as gauzes, compresses, and dressing.
The company also provides food supplements; medicinal and cosmetic products, including plasters, bandages, herbal cosmetics, and sanitary-hygiene products; and yophilic products, ointments, syrups, drops, suppositories, inhalers, haemodialysis concentrates, sachets, substances, infusion solutions, veterinary vaccines, solutions and chemical substances and mixture.
In addition, the company distributes pharmaceuticals, and sanitary and hygiene products; and provides contract manufacturing services, regulatory services, laboratory analysis, transport services, and other services.
Further, it is involved in trading of pharmaceuticals; manufacturing medical plant; and provision of public opinion research services.
Additionally, the company engages in the offline and online retail trade of medicinal products and medical equipment; and rental of properties, as well as in trading, consulting, and other activities.
Sopharma AD was founded in 1933 and is headquartered in Sofia, Bulgaria.
| Country | Bulgaria |
| Founded | 1933 |
| Industry | Pharmaceutical Preparations |
| Employees | 5,932 |
| CEO | Ognian Donev |
Contact Details
Address: 16, Iliensko Shousse St. Sofia, 1220 Bulgaria | |
| Phone | 359 28 13 42 00 |
| Website | sopharmagroup.com |
Stock Details
| Ticker Symbol | SFA |
| Exchange | Bulgarian Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | BGN |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Ognian Donev | Chief Executive Officer |
| Boris Borisov | Chief Financial Officer |
| Pelagia Viatcheva | Head of Investor Relations |